A randomized double-blind, placebo-controlled, multicentertrial assessing the impact of lipoprotein(a) lowering withpelacarsen (TQJ230) on the progression of calcific aorticvalve stenosis [Lp(a)FRONTIERS CAVS]

Project: Research project

Project Details

Description

A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS]
StatusActive
Effective start/end date4/4/24 → 4/30/34

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint